INFUSION OF ZYMOSAN-ACTIVATED PLASMA AFFECTS NEUTROPHILS IN PERIPHERAL-BLOOD AND BONE-MARROW IN SHEEP

被引:8
|
作者
ROSOLIA, DL
MCKENNA, PJ
GEE, MH
ALBERTINE, KH
机构
[1] THOMAS JEFFERSON UNIV, JEFFERSON MED COLL,DEPT MED, DIV PULM MED & CRIT CARE,804 COLL BLDG, PHILADELPHIA, PA 19107 USA
[2] THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT PHYSIOL, PHILADELPHIA, PA 19107 USA
关键词
PMN ACTIVATION; ACUTE LUNG INJURY; QUANTITATIVE MORPHOLOGY; ENZYME CYTOCHEMISTRY;
D O I
10.1002/jlb.52.5.501
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Intravenous infusion of zymosan-activated plasma (ZAP) in sheep results in acute lung injury mediated in part by free radical release from stimulated neutrophils that are retained in increased numbers in the pulmonary microcirculation. ZAP infusion is also associated with long-term reduction in elicited superoxide anion generation from segmented neutrophils in the circulating and bone marrow pools for at least 24 h after the infusion. The purpose of our study was to investigate the effect of ZAP infusion on leukocyte counts and neutrophil granule-associated enzyme activity in the circulating and bone marrow pools. Cytochemical methods were used to characterize enzyme activity in primary granules (acid phosphatase and myeloperoxidase) and secondary granules (alkaline phosphatase). During the infusion period, neutrophil differential counts decreased less in venous blood than in matched arterial blood. Release from bone marrow stores was evident as increased numbers of circulating band neutrophils during and after the infusion. Neutrophils in venous and arterial blood smears were degranulated acutely during and 1-3 h after the infusion was stopped. Band and segmented neutrophils in bone marrow also appeared slightly degranulated 1-2 h after the infusion. In vitro experiments showed that band and segmented neutrophils in bone marrow degranulated in response to ZAP incubation. Immature polymorphonuclear leukocytes did not degranulate. Five to 24 h after ZAP infusion, enzyme activity in circulating and bone marrow neutrophils was at baseline levels, suggesting that new cells were being released into the circulating pool because degranulated neutrophils do not synthesize new granules. Another indication of a long-term effect in bone marrow were slight decreases in the percentage of immature polymorphonuclear leukocytes and band neutrophils and a significant decrease in the percentage of eosinophils, all of which coincided with a significant increase in the percentage of segmented neutrophils. Our results demonstrate that circulating complement anaphylatoxins affect neutrophils in bone marrow as well as the vascular space.
引用
收藏
页码:501 / 515
页数:15
相关论文
共 50 条
  • [11] BOVINE PERIPHERAL-BLOOD POLYMORPHONUCLEAR NEUTROPHIL CHEMOTACTIC RESPONSE TO PASTEURELLA-HAEMOLYTICA OR ZYMOSAN-ACTIVATED SERUM
    BRUECKER, KA
    SCHWARTZ, LW
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1982, 43 (10) : 1879 - 1881
  • [12] BASOPHILS IN PERIPHERAL-BLOOD AND BONE-MARROW - A RETROSPECTIVE REVIEW
    MAY, ME
    WADDELL, CC
    AMERICAN JOURNAL OF MEDICINE, 1984, 76 (03): : 509 - 511
  • [13] CONTAMINATION OF BONE-MARROW TRANSPLANTS FROM PERIPHERAL-BLOOD
    FARRINGTON, M
    MATTHEWS, I
    MARCUS, R
    SCOTT, MA
    CAFFREY, E
    HUNT, CJ
    BRITISH MEDICAL JOURNAL, 1994, 309 (6959): : 958 - 958
  • [14] LEUKEMIC PERIPHERAL-BLOOD PLASMA AND BONE-MARROW PLASMA - COMPARISON OF INFLUENCE ON LYMPHOCYTE-PROLIFERATION
    SCHULTZ, JC
    CELL PROLIFERATION, 1994, 27 (01) : 47 - 61
  • [15] CYTOGENETIC PATTERNS OF BONE-MARROW AND PERIPHERAL-BLOOD IN THE EARLY POST BONE-MARROW TRANSPLANTATION PERIOD
    GODDESALZ, E
    NIEFIND, K
    SCHMITZ, N
    CLINICAL GENETICS, 1985, 27 (03) : 311 - 312
  • [16] ZYMOSAN-ACTIVATED PLASMA CAUSES PROLONGED DECREASES IN PMN SUPEROXIDE RELEASE IN SHEEP
    ALBERTINE, KH
    CERASOLI, F
    TAHAMONT, MV
    ISHIHARA, Y
    FLYNN, JT
    PETERS, SP
    GEE, MH
    JOURNAL OF APPLIED PHYSIOLOGY, 1989, 67 (06) : 2481 - 2490
  • [17] COMPARATIVE ROLE OF HUMAN CORD PLASMA ON PERIPHERAL-BLOOD PROGENITORS AND ON BONE-MARROW PROGENITORS
    SUMEREAUDASSIN, E
    FARDOUN, D
    PEULVE, P
    TEIXEIRALEBRUN, G
    VANNIER, JP
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1138 - 1138
  • [18] CYTOMEGALOVIRUS DNA IN PERIPHERAL-BLOOD LEUKOCYTES AND PLASMA FROM BONE-MARROW TRANSPLANT RECIPIENTS
    BRYTTING, M
    MOUSAVIJAZI, M
    BOSTROM, L
    LARSSON, M
    LUNDEBERG, J
    LJUNGMAN, P
    RINGDEN, O
    SUNDQVIST, VA
    TRANSPLANTATION, 1995, 60 (09) : 961 - 965
  • [19] Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis?
    Minamino, T
    Toko, H
    Tateno, K
    Nagai, T
    Komuro, I
    LANCET, 2002, 360 (9350): : 2083 - 2084
  • [20] INDOMETHACIN INHIBITION OF BONE-MARROW GRANULOCYTE RELEASE INTO PERIPHERAL-BLOOD
    PETRINI, M
    CARACCIOLO, F
    CARULLI, G
    VATTERONI, ML
    BRUSCHI, F
    POLIDORI, R
    AMBROGI, F
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1982, 2 (02) : 167 - 170